A diagnostic test kit for the combined detection of multiple gene methylations in blood samples for colorectal cancer screening and diagnosis. This in vitro diagnostic reagent kit utilizes methylation detection technology to identify cancer-related biomarkers.
Manufactured by
Singlera GENOMICS (SHANGHAI) Ltd.
China
Singlera Genomics is a China-based manufacturer of in vitro diagnostic (IVD) reagents and instruments specializing in DNA methylation-based cancer early detection and liquid biopsy testing. The company produces diagnostic products for multiple cancer types including colorectal, liver, gastric, esophageal, and pancreatic cancers, with manufacturing facilities in Yangzhou and Wuxi. Singlera holds ISO 13485 certification, CAP accreditation, US CLIA laboratory certification, and is designated as a National High-tech Enterprise in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Clinomics Europe Kft.
Hungary · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 8 relevant products
Suzhou Linaxin Biotechnology Co., Ltd.
China · 5 relevant products
45 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 96 closest product alternatives
Clinomics Europe Kft. · Hungary
Multi-gene methylation detection test for colorectal cancer screening and risk assessment. Uses advanced liquid biopsy technology to identify epigenetic biomarkers associated with colorectal malignancy. Enables non-invasive early detection and personalized patient stratification for clinical decision-making.
BioChain (Beijing) Science & Technology. Inc. · China
A blood-based gene methylation detection kit for hepatocellular carcinoma with industry-leading performance metrics. This approved product is part of BioChain's comprehensive coverage of major digestive system cancers.
BioChain (Beijing) Science & Technology. Inc. · China
Gene methylation-based diagnostic test for early detection of hepatocellular carcinoma with industry-leading performance metrics. This blood-based test enables non-invasive screening for liver cancer risk stratification. The product is approved by NMPA and integrated into multiple hospital and insurance systems.
93 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products